Letters
Child health Pharmacology
Volume 179 - Issue 10

Dosing information for paediatric patients: are they really “therapeutic orphans”?

Author:  Amanda J Caswell

Med J Aust 2003; 179 (10): 560. || doi: 10.5694/j.1326-5377.2003.tb05696.x
Published online: 17 November 2003
Download PDF (238 KB)
Share: Share on Blue Sky Share on Facebook Share on LinkedIn Share by email

Amanda J Caswell

Managing Editor, MIMS Australia, Locked Bag 3000, St Leonards, NSW 1590. amanda.caswellATmims.com.au

To the Editor: Tan et al outline deficiencies in product information documents (PIs) as published in MIMS.1 It needs to be clarified that MIMS Australia is not responsible for the content of PIs — this is specified and approved by the Therapeutic Goods Administration in consultation with the sponsoring company. The conclusion by the authors that the “PIs for many prescription products listed . . . do not adequately detail paediatric doses” should not be specifically attributed to MIMS, as all published medicines information that relies on approved PIs will suffer from the same deficiencies.

Author

  • Amanda J Caswell1
  • 1. MIMS Australia, Locked Bag 3000, St Leonards, NSW 1590.

Correspondence: amanda.caswell@mims.com.au

References

View this article on Wiley Online Library